Koyfin Home > Directory > Health Care > Aimmune Therap > Long-Term Investments

Aimmune Therap Long-Term Investments Chart (AIMT)

Aimmune Therap annual/quarterly Long-Term Investments from 2015 to 2020.
  • Aimmune Therap Long-Term Investments for the quarter ending June 06, 2020 was $4m a -22.07% decrease of -1m year over year
  • Aimmune Therap Long-Term Investments for the last 12 months ending June 06, 2020 was $4m a -22.07% decrease of -1m year over year
  • Aimmune Therap Annual Long-Term Investments for 2019 was $15m a -129.19% decrease of -19m from 2018
  • Aimmune Therap Annual Long-Term Investments for 2016 was $34m a 76.22% increase of 26m from 2015
  • Aimmune Therap Annual Long-Term Investments for 2015 was $8m
Other Cash Flow Metrics:
  • Aimmune Therap Cash Flow from Operations for the quarter ending September 09, 2018 was $-41m a 22.62% decrease of -9m year over year
  • Aimmune Therap Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-25m a 30.11% decrease of -7m year over year
View Chart On Koyfin

Quarterly AIMT Long-Term Investments Data

06/2020$4m
03/2020$13m
12/2019$15m
09/2019$5m
06/2019$7m
03/2019$13m
06/2018$6m
03/2018$10m
03/2017$13m
12/2016$34m

Annual AIMT Long-Term Investments Data

2019$15m
2016$34m
2015$8m